GLIADEL
Total Payments
$48,525
Transactions
27
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $48,525 | 27 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $48,525 | 27 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Vigilant ObservatIon of GlIadeL WAfer ImplaNT Registry (VIGILANT) | Azurity Pharmaceuticals, Inc. | $48,525 | 0 |
Top Doctors Receiving Payments for GLIADEL
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Atlanta, GA | $48,525 | 27 |
Ad
Manufacturing Companies
- Azurity Pharmaceuticals, Inc. $48,525
Product Information
- Type Drug
- Total Payments $48,525
- Total Doctors 0
- Transactions 27
About GLIADEL
GLIADEL is a drug associated with $48,525 in payments to 0 healthcare providers, recorded across 27 transactions in the CMS Open Payments database. The primary manufacturer is Azurity Pharmaceuticals, Inc..
Payment data is available from 2024 to 2024. In 2024, $48,525 was paid across 27 transactions to 0 doctors.
The most common payment nature for GLIADEL is "Unspecified" ($48,525, 100.0% of total).
GLIADEL is associated with 1 research study, including "Vigilant ObservatIon of GlIadeL WAfer ImplaNT Registry (VIGILANT)" ($48,525).